MedPage Today | U.S. Launch of Astellas' Astagraf XL - Analyst Blog NASDAQ ... received approval for Astagraf XL (tacrolimus extended-release capsules) in the U.S. for the prevention of organ rejection in patients receiving a kidney transplant with mycophenolate mofetil (MMF) and corticosteroids, with or without basiliximab ... Long-Release Tacrolimus Wins FDA Nod New Treatment Option for Kidney Transplant Recipients FDA approves Astellas once-daily organ rejection drug |
